Vital Pharmaceuticals is now a liquidating-trust case, with the confirmed operating restructuring behind it and the live fight concentrated in post-confirmation estate litigation against founder John H. Owoc, related insiders, and affiliated property entities. The debtor filed chapter 11 on October 10, 2022 after a liquidity and litigation cascade: defaults under its Truist-backed revolving and term loan structure, failed refinancing efforts, the loss of its PepsiCo distribution relationship, and major adverse litigation outcomes including the Orange Bang/Monster arbitration and Monster false-advertising verdict, all described in the DiDonato first-day declarationDkt. 26.
The case moved from operating stabilization into a liquidation path. VPX sought to preserve the Bang business through chapter 11 while managing secured-debt pressure and litigation liabilities, then filed a disclosure statement and liquidation plan in September 2023 through the Disclosure Statement for Debtors' Joint Plan of LiquidationDkt. 1874 and Second Amended Joint Plan of LiquidationDkt. 1905. The court approved the disclosure statement and confirmed the plan on November 8, 2023 through the confirmation orderDkt. 2258, leaving the estate’s remaining value path principally in liquidating-trust administration and litigation recoveries rather than a reorganized operating company.
The current docket is dominated by the VPX Liquidating Trust’s adversary proceeding against the Owoc defendants and related entities. The Trust’s January 2024 complaint asserts turnover, preference, fraudulent-transfer, declaratory-judgment, and other claims against John H. Owoc, Megan Owoc, family members, and multiple real-estate and holding entities through the . Recent pretrial filings show the dispute has narrowed into a recovery fight over alleged insider compensation, property transfers, and estate-funded carrying costs, with the parties’ admitted and contested issues laid out in the . Defendants are seeking more time to build an expert record and fund the defense; Elite Island supplemented a financing request tied to the Overseas Highway property in the , and the Owoc-side defendants then moved to extend pretrial deadlines in the .
The next practical milestone is whether the court lets the defense financing and schedule move, which would determine whether the Trust’s litigation stays on its current track or shifts into a longer expert-discovery and dispositive-motion calendar. The case calendar also shows a June 15, 2026 omnibus hearing, aligned with the unresolved financing and claims-administration posture.
